- Home
- SUM vs MEDP Comparison
SUM vs MEDP Comparison
Compare SUM & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUM
- MEDP
- Stock Information
- Founded
- SUM 2009
- MEDP 1992
- Country
- SUM United States
- MEDP United States
- Employees
- SUM N/A
- MEDP N/A
- Industry
- SUM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SUM Industrials
- MEDP Health Care
- Exchange
- SUM Nasdaq
- MEDP Nasdaq
- Market Cap
- SUM 8.9B
- MEDP 10.5B
- IPO Year
- SUM 2015
- MEDP 2016
- Fundamental
- Price
- SUM $50.64
- MEDP $342.69
- Analyst Decision
- SUM Buy
- MEDP Buy
- Analyst Count
- SUM 15
- MEDP 10
- Target Price
- SUM $50.62
- MEDP $389.00
- AVG Volume (30 Days)
- SUM 4.0M
- MEDP 257.2K
- Earning Date
- SUM 02-12-2025
- MEDP 02-10-2025
- Dividend Yield
- SUM N/A
- MEDP N/A
- EPS Growth
- SUM N/A
- MEDP 33.84
- EPS
- SUM 0.92
- MEDP 11.42
- Revenue
- SUM $3,754,547,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- SUM $58.85
- MEDP $13.95
- Revenue Next Year
- SUM $6.42
- MEDP $5.82
- P/E Ratio
- SUM $55.22
- MEDP $30.00
- Revenue Growth
- SUM 49.49
- MEDP 16.24
- 52 Week Low
- SUM $34.38
- MEDP $277.72
- 52 Week High
- SUM $53.49
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- SUM 61.22
- MEDP 51.33
- Support Level
- SUM $50.35
- MEDP $326.92
- Resistance Level
- SUM $50.75
- MEDP $342.50
- Average True Range (ATR)
- SUM 0.21
- MEDP 10.61
- MACD
- SUM -0.27
- MEDP -0.67
- Stochastic Oscillator
- SUM 44.74
- MEDP 48.42
About SUM Summit Materials Inc.
Summit Materials Inc is engaged in the production and sale of aggregates, cement, ready-mix concrete, asphalt paving mix and concrete products and owns and operates quarries, sand and gravel pits, two cement plants, cement distribution terminals, ready-mix concrete plants, asphalt plants and landfill sites. It is also engaged in paving and related services. The Company's three operating and reporting segments are the West, East and Cement segments. It operates in 21 U.S. states and in British Columbia, Canada and has assets in 21 U.S. states and in British Columbia, Canada through its platform.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.